US Patent Issued to Novartis on July 22 for "Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[Bpyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-bpyrodine-3-carboxylate as Ca v 1.2 activators" (Chinese, American Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,690, issued on July 22, was assigned to Novartis AG (Basel, Switzerland).

"Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[Bpyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-bpyrodine-3-carboxylate as Ca v 1.2 activators" was invented by Sung David C. Kim (Westwood, Mass.), Zaixing Li (Shanghai), Chui Lu (Shanghai), Danuta Lubicka (Peabody, Mass.), James Neef (Stow, Mass.), Hye-Yeon Park (Arlington, Mass.), Tejaskumar Pankajbhai Pathak (Boston), Amir Masoud Sadaghiani (Dover, Mass.) and Xilin Zhou (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclo...